These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6165428)

  • 21. Purification of mouse interferon on specifically purified immunoadsorbent.
    Hajnicka V; Fuchsberger N; Borecký L
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):619-22. PubMed ID: 597010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interferon status and the activity of dsRNA-dependent enzymes in volunteers and influenza patients receiving human recombinant alpha 2-interferon (reaferon)].
    Lavrukhina LA; Sokolova TM; Suetina IA; Kniazeva LD; Mironova LL
    Vopr Virusol; 1988; 33(5):580-5. PubMed ID: 2464241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purified interferon as protection against rhinovirus infection.
    Scott GM; Phillpotts RJ; Wallace J; Secher DS; Cantell K; Tyrrell DA
    Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1822-5. PubMed ID: 6177374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of the major species of human leucocyte interferon with the help of a monoclonal antibody.
    Laurent AG; Gruest J; Svab J; Montagnier L; Meurs E
    Dev Biol Stand; 1984; 57():305-10. PubMed ID: 6084617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two antigenically distinct species of human interferon.
    Havell EA; Berman B; Ogburn CA; Berg K; Paucker K; Vilcek J
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2185-7. PubMed ID: 49055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1a.
    Hu X; Olivier K; Polack E; Crossman M; Zokowski K; Gronke RS; Parker S; Li Z; Nestorov I; Baker DP; Clarke J; Subramanyam M
    J Pharmacol Exp Ther; 2011 Sep; 338(3):984-96. PubMed ID: 21690216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of human fibroblast interferon by zinc chelate affinity chromatography.
    Edy VG; Billiau A; de Somer P
    J Biol Chem; 1977 Sep; 252(17):5934-5. PubMed ID: 893388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.
    van 't Hull E; Schellekens H; Löwenberg B; de Vries MJ
    Cancer Res; 1978 Apr; 38(4):911-4. PubMed ID: 639045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 30. Stabilization of interferons.
    Sedmak JJ; Grossberg SE
    Tex Rep Biol Med; 1977; 35():198-204. PubMed ID: 29357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of mouse interferon by affinity chromatography on a solid-phase immunoadsorbent.
    Sipe JD; de Maeyer-Guignard J; Fauconnier B; de Maeyer E
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1037-40. PubMed ID: 4352220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I pharmacotoxicology study of human fibroblast interferon in human cancers.
    McPherson TA; Tan YH
    J Natl Cancer Inst; 1980 Jul; 65(1):75-9. PubMed ID: 6156261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly purified leucocyte interferons for renal transplant recipients.
    Weimar W; Mogensen KE; Cantell K
    Biomed Pharmacother; 1982 Mar; 36(2):94-7. PubMed ID: 6751424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physicochemical and biological properties of human placental amniotic interferon].
    Bakhutashvili VI; Merabishvili DG; Gogitashvili RV; Korsantiia BM; Dzotsenidze LL
    Vopr Virusol; 1985; 30(6):693-7. PubMed ID: 2420070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of human fibroblast interferon by zinc chelate chromatography.
    Heine JW; Van Damme J; de Ley M; Billiau A; de Somer P
    J Gen Virol; 1981 May; 54(Pt 1):47-56. PubMed ID: 6169789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SDS-polyacrylamide gel electrophoresis of purified human leucocyte interferon and the antiviral and anticellular activities of the different interferon species.
    Berg K; Heron I
    J Gen Virol; 1980 Oct; 50(2):441-6. PubMed ID: 6161993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice.
    Gresser I; Aguet M; Morel-Maroger L; Woodrow D; Puvion-Dutilleul F; Guillon JC; Maury C
    Am J Pathol; 1981 Mar; 102(3):396-402. PubMed ID: 6163363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of the safety, reactogenicity, and allergenicity of swine leukocyte interferon in experiments on animals and observations of volunteers].
    Solov'ev VD; Marchenko VI; Pozhidaev IuI; Zubanova NA; Volodina TN
    Vopr Virusol; 1981; (1):12-7. PubMed ID: 6167066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
    Furue H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.